Burkehill Global Management’s Avidity Biosciences RNAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-60,000
Closed -$4.33M 202
2025
Q4
$4.33M Hold
60,000
0.29% 83
2025
Q3
$2.61M Buy
+60,000
New +$2.43M 0.15% 109

Other funds holding RNAM

Burkehill Global Management's RNAM Position: Q1 2026 in Review

Burkehill Global Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 60,000 shares — an estimated $4.33M sold.

Burkehill Global Management first reported a position in RNAM in Q3 2025 and held it in 2 quarters. The position peaked at $4.33M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Burkehill Global Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Burkehill Global Management sold 60,000 Avidity Biosciences shares in Q1 2026, an estimated $4.33M.
  • Burkehill Global Management first reported a position in Avidity Biosciences in Q3 2025 and held it in 2 quarters.
  • Burkehill Global Management's Avidity Biosciences position peaked at $4.33M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Burkehill Global Management's 13F filing for Q1 2026, filed 15 May 2026.